An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida Albicans
- PMID: 808868
- DOI: 10.1080/00362177585190271
An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida Albicans
Abstract
A chemically defined medium composed of 6 amino acids, biotin, inorganic salts and glucose for the growth of yeast and mycelial phases of Candida albicans at 25 degrees C and 37 degrees of C respectively was developed based on the aminopeptidase(s) profile of the fungus. This medium has proved successful in maintaining the growth characteristics of both phases during serial transfers. The relative pathogenicity, virulence, invasiveness and immunogenicity of the yeast and mycelial phases are discussed.
Similar articles
-
Importance of some factors on the dimorphism of Candida albicans.Mycopathologia. 1988 Dec;104(3):129-35. doi: 10.1007/BF00437426. Mycopathologia. 1988. PMID: 3070383
-
Induction of germ-tube formation by Candida albicans in amino acid liquid synthetic medium at 25 degrees C.Mycopathologia. 1988 Feb;101(2):77-83. doi: 10.1007/BF00452890. Mycopathologia. 1988. PMID: 3278238
-
Strain variation and morphogenesis of yeast- and mycelial-phase Candida albicans in low-sulfate, synthetic medium.J Bacteriol. 1980 May;142(2):714-9. doi: 10.1128/jb.142.2.714-719.1980. J Bacteriol. 1980. PMID: 6991484 Free PMC article.
-
An effective medium for the selective growth of yeast or mycelial forms of Candida albicans: biochemical aspects of the two forms.Mycopathologia. 1980 Mar 17;70(2):67-75. doi: 10.1007/BF00443070. Mycopathologia. 1980. PMID: 6993952
-
Phospholipid composition and subcellular distribution in yeast and mycelial forms of Candida albicans.J Med Vet Mycol. 1992;30(5):355-62. doi: 10.1080/02681219280000461. J Med Vet Mycol. 1992. PMID: 1469536
Cited by
-
Genetic modification of Candida maltosa, a non-pathogenic CTG species, reveals EFG1 function.Microbiology (Reading). 2024 Mar;170(3):001447. doi: 10.1099/mic.0.001447. Microbiology (Reading). 2024. PMID: 38456839 Free PMC article.
-
Physiological adventures in Candida albicans: farnesol and ubiquinones.Microbiol Mol Biol Rev. 2024 Mar 27;88(1):e0008122. doi: 10.1128/mmbr.00081-22. Epub 2024 Mar 4. Microbiol Mol Biol Rev. 2024. PMID: 38436263 Review.
-
Anti-virulence strategy of diaryl chalcogenide compounds against Candida albicans infection.Virulence. 2023 Dec;14(1):2265012. doi: 10.1080/21505594.2023.2265012. Epub 2023 Oct 3. Virulence. 2023. PMID: 37771181 Free PMC article.
-
Candida albicans Hyphal Morphogenesis within Macrophages Does Not Require Carbon Dioxide or pH-Sensing Pathways.Infect Immun. 2023 May 16;91(5):e0008723. doi: 10.1128/iai.00087-23. Epub 2023 Apr 20. Infect Immun. 2023. PMID: 37078861 Free PMC article.
-
The GARP complex is required for filamentation in Candida albicans.Genetics. 2022 Nov 30;222(4):iyac152. doi: 10.1093/genetics/iyac152. Genetics. 2022. PMID: 36226807 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources